Thrombocytopenia and anemia associated with linezolid in patients with kidney failure [4]

Clinical Infectious Diseases

Volumn 42, Issue 10, 2006, Pages 1500-

  De Antonio, Javier Mateu ^a   Grau, Santiago ^a   Morales Molina, José Antonio ^a   Marín Casino, Mónica ^a  

^a HOSPITAL DEL MAR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; CREATININE; HEMOGLOBIN; HEPARIN; LINEZOLID; QUINIDINE; QUININE; RIFAMPICIN; UREA;

AGE; ANEMIA; CATHETER INFECTION; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; KIDNEY FAILURE; LETTER; METHODOLOGY; PRIORITY JOURNAL; RISK FACTOR; THROMBOCYTE COUNT; THROMBOCYTOPENIA; UREA NITROGEN BLOOD LEVEL;

ACETAMIDES; ANEMIA; ANTI-INFECTIVE AGENTS; HUMANS; KIDNEY FAILURE, CHRONIC; OXAZOLIDINONES; PLATELET COUNT; RETROSPECTIVE STUDIES; THROMBOCYTOPENIA;

EID: 33646449779     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/503677     Document Type: Letter

References (5)

1. Wu V, Wang Y, Wang C, et al. High frequency of linezolid-associated thrombocytopenia and anemia among patients with end-stage renal disease. Clin Infect Dis 2006; 42:66-72.
2. Frederiksen H, Schmidt K. The incidence of idiopathic thrombocytopenic purpura in adults increaes with age. Blood 1999; 94:909-13.
3. Grau S, Morales-Molina JA, Mateu-de Antonio J, et al. Linezolid: low pre-treatment platelet values could increase the risk of thrombocytopenia. J Antimicrob Chemother 2005; 56:440-1.
4. Senneville, Legout L, Valette M, et al. Risk factors for anaemia in patients on prolonged linezolid therapy for chronic osteomyelitis: a case-control study. J Antimicrob Chemother 2004;54:798-802.
5. George JN. Platelets. Lancet 2000; 355:1531-9.